ELMD - smartvest.com Debt to Book Capitalization Ratio

Corporate company logo of Electromed Inc (ELMD)

Electromed, Inc. (ELMD) is implementing ESG principles by reducing plastic packaging waste and optimizing energy consumption at its plants. The production of lung clearance systems relies on automation and machine vision to minimize manual labor. This chart illustrates the asset's price action, where the current indicator stands at 0.00. High business margins are driven by the demand for SmartVest devices and stable payments from insurance companies and Medicare.

SmartVest - ELMD Debts to Book Capitalization (period 07/04/2022 - 10/28/2026)
Flagship merchandise of SmartVest

An investment audit of Electromed, Inc. (ELMD) requires an assessment of the debt-to-equity ratio to determine the level of financial risk. This metric measures the proportion of leverage within the balance sheet structure, which allows for an evaluation of the funding stability for SmartVest device production and the company's ability to maintain its social mission and employee well-being through the historical debt-to-book capitalization ratio.

Competitors of Electromed, Inc.

DXCM: Debts to Book Capitalization|penumbrainc.com - Debts to Book Value|Debt to Book Capitalization Ratio Novanta (NOVT)|HAE - Debt to Net Assets Ratio|INSP: Debts to Book Capitalization|PRCT (Procept) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation CNMD|Debts to Book Capitalization Ratio pulsebiosciences.com|InMode - Debts to Book Capitalization|Debts to Book Value Picard Medical Corp PMI|Debt to Book Value SRDX (Surmodics Corp)|SENS - Debts to Book Capitalization|Debt to Book Value NeuroPace, Inc. NPCE|TCMD - Debt to Book Capital|SANUWAVE - Debts to Book Capitalization|Outset Medical Inc (OM) - Debts to Net Assets|Debts to Book Capitalization LNSR|Debt to Book Value AVITA Medical Inc (RCEL)|Profound Medical Corp. (PROF) - Debt to Book Value|Debt to Net Assets Ratio BDMD (bairdmed.com)|EDAP TMS - Debt to Book Capitalization Ratio|Debt to Book Value Apyx Medical Corp APYX|ICCM (IceCure Medical, Ltd.) - Debts to Book Capitalization|LUNG - Debts to Book Value|Debts to Book Capitalization telabio.com|CytoSorbents Corporation (CTSO) - Debt to Book Value Ratio|SRTS: Debts to Book Capitalization|Debts to Net Assets Zynex Medical|Debts to Book Capitalization ECOR (electroCore, Inc.)|Debt to Book Value vicarioussurgical.com (RBOT)|Debts to Book Capitalization IINN (Inspira Technologies)|seastarmedical.com - Debts to Book Capitalization|IRIX - Debt to Book Capitalization Ratio|Intelligent Bio Solutions (INBS) - Debt to Book Capitalization Ratio|Debt to Book Value beyondair.net XAIR|Profusa, Inc (PFSA) - Debt to Net Assets Ratio|Debts to Book Capitalization SSKN (STRATA Skin Sciences Inc.)|Debts to Book Value GCTK|NAOV: Debt to Book Capitalization Ratio|Debt to Net Assets Venus Concept Inc VERO|Debt to Book Value NUWE (CHF Solutions)|Debts to Book Capitalization Aethlon Medical Corp AEMD|Debts to Book Capitalization ASXC (TransEnterix)|AVGR: Debts to Net Assets|Debt to Book Capitalization Ratio Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio KNW|Debt to Book Value Inari Medical Corp|Nevro Corp. - Debts to Book Capitalization|Debts to Book Value RSLS (reshapelifesciences.com)|SILK - Debt to Book Capitalization Ratio